Literature DB >> 26746473

JAMA PATIENT PAGE. Treatment of Liver Cancer.

Ali A Mokdad, Amit G Singal, Adam C Yopp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26746473     DOI: 10.1001/jama.2015.15431

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Short-term Outcomes of Laparoscopic vs. Open Hepatectomy for Primary Hepatocellular Carcinoma: A Prospective Comparative Study.

Authors:  Li Zeng; Min Tian; Si-Si Chen; Yu-Ting Ke; Li Geng; Sheng-Li Yang; Lin Ye
Journal:  Curr Med Sci       Date:  2019-10-14

2.  Comments on "JAMA PATIENT PAGE. Treatment of Liver Cancer".

Authors:  Chengpei Zhu; Qinjuan Qian; Xiangchao Meng; Haitao Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

3.  Pine needle oil induces G2/M arrest of HepG2 cells by activating the ATM pathway.

Authors:  Bing Qiu; Wei Jiang; Wenliang Qiu; Wenling Mu; Yujing Qin; Yongcui Zhu; Jianying Zhang; Qingyi Wang; Dongjie Liu; Zhangyi Qu
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

Review 4.  Causal role of infectious agents in cancer: An overview.

Authors:  Jila Masrour-Roudsari; Soheil Ebrahimpour
Journal:  Caspian J Intern Med       Date:  2017

5.  Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.

Authors:  Nan Zhang; Jiajia Gu; Li Yin; Jing Wu; Ming-Yu Du; Kai Ding; Teng Huang; Xia He
Journal:  Oncotarget       Date:  2016-12-06

6.  Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations.

Authors:  Ting Zhao; Li Jia; Jun Li; Chen Ma; Jingyu Wu; Jiechen Shen; Liuyi Dang; Bojing Zhu; Pengfei Li; Yuan Zhi; Rongxia Lan; Yintai Xu; Zhifang Hao; Yichao Chai; Qingshan Li; Liangshuo Hu; Shisheng Sun
Journal:  Front Oncol       Date:  2020-04-21       Impact factor: 6.244

Review 7.  PCAF fine-tunes hepatic metabolic syndrome, inflammatory disease, and cancer.

Authors:  Tongxin Wang; Weilei Yao; Yafei Shao; Ruilong Zheng; Feiruo Huang
Journal:  J Cell Mol Med       Date:  2018-09-14       Impact factor: 5.310

8.  Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.

Authors:  Ping Li; Yu Liu; Qiang He
Journal:  Drug Des Devel Ther       Date:  2020-04-29       Impact factor: 4.162

Review 9.  Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer.

Authors:  Yitong Li; Ruihang Zhang; Zhen Xu; Zhicheng Wang
Journal:  Int J Nanomedicine       Date:  2022-02-26

10.  A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.

Authors:  Fumao Bai; Huaibin Zhou; Mengni Ma; Chen Guan; Jianxin Lyu; Qing H Meng
Journal:  Mol Oncol       Date:  2018-05-21       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.